APA (7th ed.) Citation

Shlobin, O. A., Bruce, G., Gomez‐Rendon, G., Kingman, M., Rahman, M., Rogers, F., . . . McEvoy, C. (2024). Practices affEcting macitentan and selexipag patient persistence Rates utilizing pulmonary arterial hypertension clinical Site and patIent perSpecTives (PERSIST): A US qualitative analysis. Pulmonary Circulation, 14(4), 1. https://doi.org/10.1002/pul2.12441

Chicago Style (17th ed.) Citation

Shlobin, Oksana A., Gary Bruce, Gabriela Gomez‐Rendon, Martha Kingman, Mohammad Rahman, Frances Rogers, Sean Studer, Tobore Tobore, and Colleen McEvoy. "Practices AffEcting Macitentan and Selexipag Patient Persistence Rates Utilizing Pulmonary Arterial Hypertension Clinical Site and PatIent PerSpecTives (PERSIST): A US Qualitative Analysis." Pulmonary Circulation 14, no. 4 (2024): 1. https://doi.org/10.1002/pul2.12441.

MLA (9th ed.) Citation

Shlobin, Oksana A., et al. "Practices AffEcting Macitentan and Selexipag Patient Persistence Rates Utilizing Pulmonary Arterial Hypertension Clinical Site and PatIent PerSpecTives (PERSIST): A US Qualitative Analysis." Pulmonary Circulation, vol. 14, no. 4, 2024, p. 1, https://doi.org/10.1002/pul2.12441.